FDA Inspection 1010155 — Paul Tarnasky, MD

Paul Tarnasky, MD — FEI 3012967665

The FDA completed an inspection of Paul Tarnasky, MD on April 21, 2017 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 21, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)